Illumina, Inc.

Two of the first targeted gene therapies for cancer were developed in part by Sue Desmond-Hellmann. Now she’s joining us at our inaugural virtual SPARK event. Sign up now! #SPARKbyIllumina https://bddy.me/328vVoj

Future casting with CEO Francis DeSouza. In an interview with Axios he discusses a future where genomic data will increasingly drive health care and genetics will become "the foundational element of your health record.

In a recent interview with Reuters, CEO Francis DeSouza maintained the company’s intent to acquire GRAIL, Inc., creator of a first-of-kind blood test for early detection of cancer. This acquisition provides huge benefits to people who may have cancer and don't know it, he said.

We’re proud to share our Corporate Social Responsibility report detailing our commitment to serve as a champion for patients, people, and planet.

The microscope. The internet. Technological leaps happen only so oftenand according to The New York Times Magazine, we’re embarking on a breakthrough era led by genomic sequencing. See how the world’s response to the catastrophe of Covid-19 is leading to innovations in human health and the study of disease like we’ve never seen before. Essential reading for your weekend. https://bddy.me/39kFLYj